abstract |
The present invention relates to a novel 4-amino-imidazoquinoline compound of the following formula,n□ wherein R1 to R4 are as defined in the specification and claims, as well as pharmaceutically acceptable salts thereof. These compounds are TLR agonists and are therefore useful as agents for the treatment of diseases such as cancer or infectious diseases. |